(Sharecast News) - Life sciences group Aptamer on Monday announced a new fee-for-service development contract with an unnamed top 10 global pharma company.
The contract, valued at £112,000, represents "success-based repeat business with an existing partner", Aptamer said.

It will focus on the development of Aptamer's Optimer binders against two...

Email this article to a friend

or share it with one of these popular networks:

• DIGG
• FACEBOOK
• STUMBLEUPON
• MIXX
• YAHOO BUZZ
• DELICIOUS
• REDDIT
• NEWSVINE